Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let's say that the lawsuit leads to a 10 million dollar settlement. CVSI has no debt, so it could easily finance the difference between its $7.3 million war chest of cash and the $10 million. Let's just play and imagine. CVSI will still continue to increase revenue and cash. The Farm Bill will still get passed. The CBD industry will still grow at 59% compounding annual interest rate. The overall CBD industry will still grow to $2.1 billion within a few years. CVSI will still be a market share leader and have strong presence in the industry. I don't think many people understand just how insignificant a baseless class-action lawsuit will be when compared to the money-making-potential of CVSI in the long term. This company could be very attractive to a company like Philip Morris, and the big wigs have been circling around the industry. The moment the Farm Bill passes, expect CBD companies--especially ones that source CBD from the hemp variety--to shoot up through the roof in a manner similar to Tilray. CVSI has a hard-to-reproduce product that passes the VRIO framework test, and its financials are just lovely. I assure you that those that don't invest will miss out super big!
“‘The good news is I have seen no disagreement that should prevent us from completing a strong farm bill on time,’ he said. The current farm bill expires at the end of September.”
Capital Press on Farm Bill
Farm bill deadline September 30. $$$
Long and strong on this future success story! Buy Buy Buy!
Still expecting great things from LBUY!
This gem has hidden potential. It has a CEO that knows how to get stuff done, and it has a future business portal and a website that can facilitate cannabis firms' successes. In a booming industry where many areas such as Ontario will be online-only for a while, online cannabis sourcing will be in high demand which will certainly increase firms' demand for MSRT. It's a win-win for the industry, and now, I see why Aphria is still partnered with MSRT. There may be other players in this space, but there are a lot of businesses competing for maximum exposure, and MSRT is going to be a place to get that exposure. It will be good competition for Leafly and Weedmaps. This is one of those companies like Tesla that looks like it won't be successful by the financials but has many tricks up its sleeve.
People don't even know the potential this first mover has in the CBD space right now. What a hidden gem. This could be a gold-mine in the LT.
Keep at it with the negative talk. Keeping the price nice and low so I can buy in for a discount. Ty Andrew Left.
Just a little bit of good news on revenues, and this will take off.
Patience is a virtue for a reason. Good news will come, and when it does, this will blast off! You’ll see.
Cover now, and let’s let this baby fly.
Great news coming soon! Great time to load up while the unknowledgable are confused.
What's your assessment?
Lawsuit will fizzle if CVSI gets patent approval. Can you claim that they didn't provide accurate information if it gets approved? Check this out from CVSI, "We will continue to prosecute the ‘617 Application and plan to file and prosecute several more applications related to the inventions described in the ‘617 Application.”
Why would you sell on an upswing? Stop day-trading and hold long so we can take this to where it belongs. Green candles ahead!
Another big jump coming!
All up from here. Better take notice unless you want to be in the red. The seeking alpha article from last night was proven biased by me on this forum at Aug 29 1:36 AM ET
SHORT COVERED BY CITRON FOR 70% GAIN All up from here boys.
Updated article. Just released.
CV Sciences, Inc. Responds to Class Action Lawsuit
Here, I point out bias in article called CV Sciences: Investors Should Watch These Risks below. This biased article was surely intended to drive down the price to most likely create an opening for the author to get in at a cheap price.
Here’s how it’s biased:
--Doesn’t mention that the new CEO is risking his reputation for this business. Doesn’t delve into the new CEO’s history. –The article only focuses on the founder’s actions which are ancient history, and current investors most likely already realize that risk. Why doesn’t the author mention this?
--Doesn’t mention the States Act which Trump already agreed to sign, which would change the Controlled Substances Act to allow states to make up their owns minds in regard to marijuana laws, and the federal government would respect the laws of states that have legalized. Two identical versions of the bill are currently circulating through both chambers of Congress. Why doesn’t the author mention this? Is his sole intention to scare investors to create an opportunity for himself?
--He also doesn't mention that Sen. Cory Gardner had a meeting with Trump about this States Act. Gardner was holding up Trump's justice picks until he had confidence that Trump would do something about the disconnect between the Fed and the states in regards to cannabis. After the meeting, Gardner came out smiling and stopped holding Trump's justice picks. I wonder why? Was it because Trump said he would sign the States Act if it reached his desk. --It was.
--Doesn’t mention Farm Bill of 2018 which just passed the Senate which would allow all 50 states to grow, sell, process, and distribute hemp with little restriction. CVSI makes their CBD product from hemp which is a low THC strain of Cannabis Sativa L. Why didn’t the author mention this?
--Since America likes to remain competitive globally considering our global business environment and all of the FDI, I would imagine that the United States would follow suit with Canada to buff up profit levels by bringing money back into the country that was extracted by foreign drug cartels. Much of the profit in this industry is most likely displacing unaccounted-for money in the black market. I expect legalization in the near future as well since a majority of the nation’s citizens would prefer legalization, and it’s on the Democrat’s party platform to legalize. This a democracy, right? Why didn’t the author mention any of this?
--“The DEA says you can’t get CBD in usable quantities out of those stalks and seeds;” the DEA has also taken bribes from drug lords in Columbia. The DEA has also lied about the effects of marijuana in the past, and the science has proven it. We may “need more research,” but cannabis has been used since the time of Emperor Shen Nung in China in 2800 BC. It was even in the pharmacopoeia –meaning the knowledge is there; you just have to look for it. Most importantly, cannabis sativa L (industrial hemp) stalks and seeds do contain CBD in trace amounts, and with large enough quantities, CBD can be extracted. “Unpractical” as the DEA says? –Yes, unpractical since ideally you would want to use the buds of the plant to extract CBD; that will be allowed if the Farm Bill of 2018 passes. –It just passed the Senate –headed by McConnell himself.
--Also, I want to point out that the author misstated what the DEA said. The DEA said it was not “practical” to make CBD from stalks and seeds, but they didn’t say that you “can’t” make CBD from the stalks and seeds. Is this a clever way to put words in the DEA’s mouth by the author and seem legit due to the oversized length of his boring article?
--The author claims “the DEA moved an FDA-approved THC drug (Marinol) from Schedule I to Schedule II while keeping THC on Schedule I,” and he uses this as a basis to assume that the FDA won’t recommend the rescheduling of cannabis. However, the FDA also claims that, “Schedule 1 (I) drugs, substances, or chemicals are defined by the federal government as drugs with no currently accepted medical use and a high potential for abuse.” Cannabis is a schedule 1 drug, and GW Pharmaceutical’s Epidiolex is sourced from cannabis, and since it was recently approved by the FDA, it creates a conflict of interest between the drug’s approval and the Schedule 1 classification. At this point in the article, it was apparent that the author’s general knowledge about the cannabis market is lacking. The FDA didn’t have to change cannabis’ scheduling by approving Marinol since the THC was synthetic and not considered “marihuana,” but they will have to change scheduling on the CSA after approval of Epidiolex due to the conflict of interest. I was thinking that the author should get another job at this point.
--The author claims that “the fact that CVSI has not publicly acknowledged the risk of DEA enforcement or the FDA's rejection of industry submissions on CBD is alarming.” However, per Cornell’s page on “(Item 305) Quantitative and qualitative disclosures about market risk,”it clearly states “(e)Smaller reporting companies. A smaller reporting company, as defined by § 229.10(f)(1), is not required to provide the information required by this Item.” So why should they disclose risks that most people already realize when they are not required to as a small reporting company? –To satisfy the biased author I guess.
The author (Wallace Lee) claims “Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.” But after 72 hours, I’m sure the author will be all over investing in it once his clearly biased article (as described above) has its negative affect on the novice, weak-handed CVSI investor’s ticker price.
This article was referenced to write the above:
CV Sciences: Investors Should Watch These Risks
’ll be eating popcorn when Left is tossed in a cell and forced to pay a ginormous fine for his ploy which lacks real merit. If proven to lack merit, it could be considered as slander, and that is a serious offense. Don’t drop the soap!!!
Dowling owned Left with “ignorant” statement! Left got owned! Buy buy buy now!
Buy! CVSI responded to lawsuit!
Buy buy buy! Near unlimited potential.
Buy this now! Great!
Buy buy buy! Buy it now while you can at a discount special!
Buy buy buy! Don’t wait til too late!
Buy CSVI now. I would not let you down.
Rebounding to 7. 1 year forecast at 13.63 on walletinvestor
Rebound happening!
This was a manufactured drop so big dogs can take the shares from weak-hands for pennies. --Taking candy from babies.
I hate saying it, but I was right about HIPH going up more. Sorry, had to point that out.
Positive 12%. Impressive.
Thank you for the cheap shares bears. Loaded up much more at 4.95.
Still loading. This one will be explosive when it takes off; by then, it will be too late to get the best margins.
There may be some large asks that are dumping --trying to trigger a massive sell-off that won't happen. They want your cheap shares! They want them bad! They are sitting on the side-lines like hyenas waiting for you to shake your weak hands!
Could reach $1.00 kinda easily if it gets enough demand. The CBD market is a big space, and they have a first mover advantage in the CBD water market. HIPH is only just getting started.
Congratulations to all invested in HIPH. What are you going to do with your new yachts when HIPH takes advantage of its first-mover advantage? Where will you travel?
I don't know. I think it could multiply to even higher levels than that considering that it held strong at .25 for months.